SALADAX BIOMEDICAL INC has a total of 98 patent applications. Its first patent ever was published in 2005. It filed its patents most often in United States, EPO (European Patent Office) and WIPO (World Intellectual Property Organization). Its main competitors in its focus markets measurement, machines and biotechnology are SALAMONE SALVATORE J, OHMICRON CORP and BIO RES LAB INC.
# | Country | Total Patents | |
---|---|---|---|
#1 | United States | 24 | |
#2 | EPO (European Patent Office) | 20 | |
#3 | WIPO (World Intellectual Property Organization) | 14 | |
#4 | Canada | 11 | |
#5 | China | 10 | |
#6 | Brazil | 5 | |
#7 | Hong Kong | 5 | |
#8 | Japan | 5 | |
#9 | Australia | 4 |
# | Industry | |
---|---|---|
#1 | Measurement | |
#2 | Machines | |
#3 | Biotechnology | |
#4 | Organic fine chemistry | |
#5 | Pharmaceuticals |
# | Name | Total Patents |
---|---|---|
#1 | Courtney Jodi Blake | 83 |
#2 | Salamone Salvatore J | 56 |
#3 | Salamone Salvatore | 34 |
#4 | Stocker Dennis | 34 |
#5 | Sard Howard | 28 |
#6 | Volkov Alexander | 14 |
#7 | Spedaliere Christopher | 14 |
#8 | Hegde Vishnumurthy | 12 |
#9 | He Shu | 12 |
#10 | Gul Waseem | 10 |
Publication | Filing date | Title |
---|---|---|
US2014273023A1 | Gemcitabine immunoassay | |
US2010068827A1 | Stabilized standards for busulfan immunoassay | |
EP1864129A1 | Doxorubicin immunoassay | |
WO2006055453A1 | Enzymatic measurement of imatinib mesylate | |
WO2006031912A2 | Busulfan immunoassay | |
US2006024769A1 | Taxol immunoassay | |
US2006024752A1 | Cytoxan antibodies and immunoassay | |
US2006216767A1 | Docetaxel immunoassay | |
US2006024748A1 | Cytoxan antibodies and immunoassay | |
US2006177883A1 | 5-Fluoro-uracil immunoassay | |
US2006024768A1 | Taxol immunoassay |